Higgins, R; Hathaway, M; Lowe, D; Zehnder, D; Krishnan, N; Hamer, R; Briggs, D (2008). New choices for patients needing kidney transplantation across antibody barriers. Journal of Renal Care, 34(2):85-93.
Full text not available from this repository.
View at publisher
Antibodies in the blood of a kidney transplant recipient can provide a barrier to transplantation, which is additional to the usual possibility of cellular rejection. The antibodies most frequently encountered are ABO (blood group) and human leucocyte antigen (HLA) (tissue-type) antibodies. About 250 living donor transplants each year in the United Kingdom have been stopped because of an antibody barrier. It is now possible to offer a choice of treatment modalities to these people, including exchange transplantation and antibody-incompatible transplantation. It is likely that both schemes will complement each other and both are available in the United Kingdom.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic|
|DDC:||610 Medicine & health|
|Deposited On:||03 Mar 2009 12:07|
|Last Modified:||23 Nov 2012 14:17|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page